Full Text PAR-97-012
NIH GUIDE, Volume 25, Number 41, November 29, 1996
PA NUMBER:  PAR-97-012
P.T. 34

  Communicative Disorders, Hearing 
  Communicative Disorders, Speech 

National Institute on Deafness and Other Communication Disorders
Application Receipt Date:  December 20, 1996; April 22, 1997; August
22, 1997
This program announcement (PA) supersedes all previous program
announcements of the National Institute on Deafness and Other
Communication Disorders (NIDCD) Small Grant (R03) Program for support
of pilot research that is likely to lead to a subsequent individual
research project grant (R01) or a First Independent Research Support
and Transition (FIRST) (R29) award application.  The research must be
focused on one or more of the areas within the biomedical and
behavioral scientific mission of the NIDCD: hearing, balance, smell,
taste, voice, speech, or language.
The Public Health Service (PHS) is committed to achieving the health
promotion and disease prevention objectives of "Healthy People 2000,"
a PHS-led national activity for setting priority areas.  This PA,
Small Grant Program for the NIDCD, is related to the priority area of
clinical prevention services.  Potential applicants may obtain a copy
of "Healthy People 2000" (Full Report:  Stock No. 017-001-11474-0 or
Summary Report: Stock No. 017-001-11473-1) through the Superintendent
of Documents, Government Printing Office, Washington, DC 20402-9325
(telephone 202-512-1800).
Applications may be submitted by domestic for-profit and non-profit
organizations, public and private, such as universities, colleges,
hospitals, laboratories, units of state and local governments, and
eligible agencies of the Federal government.  Racial/ethnic minority
individuals, women, and persons with disabilities are encouraged to
apply. Institutions located in foreign countries are not eligible to
apply for this program.
Current and previous recipients of NIH research grants such as
Research Project Grants (R01), FIRST (R29), or NIH Academic Research
Enhancement Awards (R15) awards are ineligible for this Small Grant
Program, as are principal investigators of research subprojects of
Research Program Projects (P01) and Centers (P50 and P60).  Current
and previous recipients of Small Grants (R03), excluding Minority
Dissertation Small Grant Awards, are also ineligible.  Individuals
who have served as principal investigators on other Federally-funded
research grants are also ineligible.
Before completion of the R03, investigators are encouraged to seek
continuing support for a promising program of research through a
research project grant (R01) or FIRST (R29) award.  However, R01 or
R29 support may not be held concurrently with an R03 until the final
year of the R03 support.  Guidelines addressing scientific and
budgetary overlap still apply.
Former recipients of Mentored Research Scientists Development Awards
(K01), or Mentored Clinical Scientist Development Awards (K08)
(formerly called Clinical Investigator Development Awards) are
eligible for this Small Grant Program; however, an individual may not
hold an R03 award concurrently with a K01 or K08 award.  Former
recipients of Individual (F32) or Institutional (T32) National
Research Service Award training support are eligible for this Small
Grant Program; however, the Small Grant award cannot be held
concurrently with this support.
Investigators who have questions about eligibility should contact one
of the program officials listed under INQUIRIES.
This PA will use the small grant (R03) mechanism.  The small grant
funds may not be used to supplement projects currently supported by
Federal or non-Federal funds, or to support thesis or dissertation
research.  Applicants may request up to $35,000 (direct costs) per
year through the R03 mechanism.  The grant may not exceed three years
and is not renewable.
The Small Grant Program is designed to support basic and clinical
research of scientists who are in the early stages of pursuing an
independent research career.
It is the policy of the NIH that women and members of minority groups
and their subpopulations must be included in all NIH supported
biomedical and behavioral research projects involving human subjects,
unless a clear and compelling rationale and justification are
provided that inclusion is inappropriate with respect to the health
of the subjects or the purpose of the research.  This policy results
from the NIH Revitalization Act of 1993 (Section 492B of Public Law
103-43) and supersedes and strengthens the previous policies
(Concerning the Inclusion of Women in Study Populations, and
Concerning the Inclusion of Minorities in Study Populations) which
have been in effect since 1990.  The new policy contains some
provisions that are substantially different from the 1990 policy.
All investigators proposing research involving human subjects should
read the "NIH Guidelines for Inclusion of Women and Minorities as
Subjects in Clinical Research", which have been published in the
Federal Register of March 28, 1994 (FR 59 14508-14513) and reprinted
in the NIH Guide for Grants and Contracts, Volume 23, Number 11,
March 18, 1994.  Investigators also may obtain copies of the policy
from the program staff listed under INQUIRIES.  Program staff also
may provide additional relevant information concerning the policy.
Applications are to be submitted on the grant application form PHS
398 (rev. 5/95) and prepared according to the directions in the
application packet, with the exceptions noted below.  Applications
kits are available at most institutional offices of sponsored
research and may be obtained from the Grants Information Office,
Office of Extramural Outreach and Information Resources, National
Institutes of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD
20892-7910, telephone 301/710-0267, email:
On the face page of the application:  Item 2, Type "Small Grant
Program NIDCD" in "Title" box.  Check the "YES" box.  Sections a-d:
Do not exceed a total of five pages for the following sections:
Specific Aims, Background and Significance, Preliminary
Studies/Progress Report, and Research Design and Methods.  Tables and
figures are included in the five page limitation.  For revised
applications, an additional introduction not to exceed one-half page
is allowed.  This introduction should respond to the comments and
concerns of the Initial Review Group delineated in the summary
statement. Applications that exceed the page limitation or NIH
requirements for type size and margins (refer to PHS 398 application
for details) will be returned to the investigator. The five page
limitation does not include Sections e-i (Human Subjects, Vertebrate
Animals, Consortia, Literature Cited, etc.). Appendix materials are
not allowed.
Use the mailing label in the application kit to mail the original and
three copies of the application to:
BETHESDA, MD  20892-7710
BETHESDA, MD  20817 (for express/courier service)
To ensure that the application is received in sufficient time for the
review, send two copies of the application to:
Acting Chief, Scientific Review Branch
National Institute on Deafness and Other Communication Disorders
Executive Plaza South, Room 400-C
6120 Executive Boulevard MSC 7180
Bethesda, MD  20892-7180
Rockville, MD 20852 (for express/courier service)
The submission, review, and award schedule for the Small Grant
Program for FY 97
(these dates likely will differ for FY 98) is:
Application Receipt Dates for:  Dec 20         Apr 22      Aug 22
NIDCD Committee Review:         Feb/Mar        Jun/Jul     Oct/Nov
Council Review:                 May            Oct         Jan
Earliest Funding:               Aug            Jan         May
Only one Small Grant application may be submitted by a principal
investigator per receipt date.  Applicants may not submit an R01 or
R29 application on the same topic concurrently (to be considered at
the same National Advisory Council cycle) with the submission of a
Small Grant application.
A review committee of the NIDCD will evaluate each Small Grant
application in accordance with the usual NIH peer review procedures
and criteria, which include:
o  Scientific, technical, or clinical significance and originality of
the proposed research.
o  Appropriateness and adequacy of the experimental approach and
methodology proposed to carry out the research.
o  Appropriateness of the statistical methods proposed to analyze the
o  Potential of the proposed studies to lead to more extensive
o  Qualifications and research experience of the principal
o  Availability of resources necessary to conduct the research,
including information beyond what is requested in the submitted
budget (such as support for salaries, equipment and supplies).
o  Appropriateness of the proposed budget, resources, and timetable
in relation to the scope of the proposed research.
o  The adequacy of the proposed means for protecting against or
minimizing potential adverse effects upon humans, animals, or the
o  Adequacy of adherence to guidelines for including gender and
minority representation in any study population involving humans.
Applications will be subsequently reviewed by the National Deafness
and Other Communication Disorders Advisory Council.
The award of grants is contingent on (1) the receipt of applications
of high scientific merit; (2) responsiveness to this program
announcement, including the eligibility of investigators;
(3)relevance to the mission of the NIDCD; and (4) the availability of
appropriated funds.
Inquiries are encouraged.  The opportunity to clarify any issues or
questions from potential applicants is welcome.
Direct inquiries regarding programmatic issues to:
Dr. Chyren Hunter
Telephone:  (301) 402-3461
Email:  Chyren_Hunter@NIH.GOV
Dr. Daniel Sklare
Telephone:  (301) 496-1804
Email:  Daniel_Sklare@NIH.GOV
Dr. Jack Pearl
Telephone:  (301) 402-3464
Email:  Jack_Pearl@NIH.GOV
Dr. Rochelle Small
Telephone:  (301) 402-3464
Email:  Rochelle_Small@NIH.GOV
Dr. Beth Ansel
Telephone:  (301) 402-3461
Email:  Beth_Ansel@NIH.GOV
Dr. Judith Cooper
Telephone:  (301) 496-5061
Email:  Judith_Cooper@NIH.GOV
The address and FAX number for the above named persons are:
Division of Human Communication
National Institute on Deafness and Other Communication Disorders
Executive Plaza South, Room 400-C
6120 Executive Boulevard MSC-7180
Bethesda, MD  20892-7180
FAX:  (301) 402-6251
Direct inquiries regarding fiscal matters to:
Sharon Hunt
Grants Management Office
National Institute on Deafness and Other Communication Disorders
Executive Plaza South, Room 400-B
6120 Executive Boulevard MSC-7180
Bethesda, MD  20892-7180
Telephone:  (301) 402-0909
This program is described in the Catalog of Federal Domestic
Assistance No. 93.173. Awards are made under authorization of the
Public Health Service Act, Title IV, Part A (Public Law 78-410), as
amended by Public Law 99-158, 42 USC 241 and 285) and administered
under PHS grants policies and Federal Regulations 42 CFR 52 and 45
CFR Part 74.  This program is not subject to the intergovernmental
review requirements of Executive Order 12372 or Health Systems Agency
The PHS strongly encourages all grant and contract recipients to
provide a smoke-free workplace and promote the non-use of all tobacco
products.  In addition, Public Law 103-227, the Pro-Children Act of
1994, prohibits smoking in certain facilities (or in some cases, any
portion of a facility) in which regular or routine education,
library, day care, health care or early childhood development
services are provided to children.  This is consistent with the PHS
mission to protect and advance the physical and mental health of the
American people.

Return to PA Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.